TherapeuticsMD, Inc. (TXMD) News
Follow TherapeuticsMD, Inc. (TXMD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
TherapeuticsMD Q2 EPS $0.01 Down From $0.05 YoY, Sales $869.000K Down From $952.000K YoY
TherapeuticsMD (NASDAQ: TXMD ) reported quarterly earnings of $0.01 per share. This is a 80 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $869.000 thousand in sale
EARNINGS | Aug 11, 2026, 08:30 PM UTC
L
TXMD - TherapeuticsMD Announces Second Quarter 2026 Financial Results
TXMD - TherapeuticsMD Announces Second Quarter 2026 Financial Results
EARNINGS | Aug 11, 2026, 08:08 PM UTC